C. Gordon

发表

Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF therapy (IMSAT) therapeutic drug monitoring study

Thomas M. Riley, C. Lees, T. Ahmad, 2022, Alimentary pharmacology & therapeutics.

Root‐cause analyses of missed opportunities for the diagnosis of colorectal cancer in patients with inflammatory bowel disease

T. Ahmad, N. Kennedy, E. Wesley, 2020, Alimentary pharmacology & therapeutics.